174 related articles for article (PubMed ID: 9363783)
1. Fluoresceinyl-ethylenediamine-ouabain detects an acidic environment in the cardiac glycoside binding site of Na+/K+-ATPase.
Brinkmann K; Linnertz H; Amler E; Lanz E; Herman P; Schoner W
Eur J Biochem; 1997 Oct; 249(1):301-8. PubMed ID: 9363783
[TBL] [Abstract][Full Text] [Related]
2. Identification of a model cardiac glycoside receptor: comparisons with Na+,K+-ATPase.
Kasturi R; Yuan J; McLean LR; Margolies MN; Ball WJ
Biochemistry; 1998 May; 37(19):6658-66. PubMed ID: 9578549
[TBL] [Abstract][Full Text] [Related]
3. Interaction between cardiotonic steroids and Na,K-ATPase. Effects of pH and ouabain-induced changes in enzyme conformation.
Cornelius F; Mahmmoud YA
Biochemistry; 2009 Oct; 48(42):10056-65. PubMed ID: 19778013
[TBL] [Abstract][Full Text] [Related]
4. Evidence for tryptophan residues in the cation transport path of the Na(+),K(+)-ATPase.
Yudowski GA; Bar Shimon M; Tal DM; González-Lebrero RM; Rossi RC; Garrahan PJ; Beaugé LA; Karlish SJ
Biochemistry; 2003 Sep; 42(34):10212-22. PubMed ID: 12939149
[TBL] [Abstract][Full Text] [Related]
5. Anthroylouabain: a specific fluorescent probe for the cardiac glycoside receptor of the Na-K ATPase.
Fortes PA
Biochemistry; 1977 Feb; 16(3):531-40. PubMed ID: 138437
[TBL] [Abstract][Full Text] [Related]
6. Effect of ouabain binding on the fluorescent properties of the Na+/K+-ATPase.
Grimaldi S; Pascale E; Pozzi D; D'Onofrio M; Giganti MG; Verna R
Biochim Biophys Acta; 1988 Sep; 944(1):13-8. PubMed ID: 2843233
[TBL] [Abstract][Full Text] [Related]
7. [The calixarenes C-97 and C-107 stimulate influence of ouabain on the Na+,K+-ATPase activity in plasmatic membrane of smooth muscle cells].
Veklich TO; Shkrabak OA; Kosterin SO; Rodik RV; Cherenok SO; Boĭko SO; Boĭko VI; Kal'chenko VI
Ukr Biokhim Zh (1999); 2006; 78(6):53-63. PubMed ID: 17494319
[TBL] [Abstract][Full Text] [Related]
8. Ovine cardiac Na,K-ATPase: isolation by means of selective solubilization in Lubrol and the effect of 1 alpha,2 alpha-epoxyscillirosidin on this enzyme.
Venter PA; Naudé RJ; Oelofsen W; Swan GE
Int J Biochem Cell Biol; 1997; 29(8-9):1103-12. PubMed ID: 9416006
[TBL] [Abstract][Full Text] [Related]
9. Modification of the E1ATP binding site of Na+/K(+)-ATPase by the chromium complex of adenosine 5'-[beta,gamma-methylene]triphosphate blocks the overall reaction but not the partial activities of the E2 conformation.
Hamer E; Schoner W
Eur J Biochem; 1993 Apr; 213(2):743-8. PubMed ID: 8386635
[TBL] [Abstract][Full Text] [Related]
10. Ouabain interactions with the H5-H6 hairpin of the Na,K-ATPase reveal a possible inhibition mechanism via the cation binding domain.
Palasis M; Kuntzweiler TA; Argüello JM; Lingrel JB
J Biol Chem; 1996 Jun; 271(24):14176-82. PubMed ID: 8662895
[TBL] [Abstract][Full Text] [Related]
11. Ouabain-sensitive Na+,K(+)-ATPase activity in toad brain.
Morris JF; Ismail-Beigi F; Butler VP; Gati I; Lichtstein D
Comp Biochem Physiol A Physiol; 1997 Nov; 118(3):599-606. PubMed ID: 9406436
[TBL] [Abstract][Full Text] [Related]
12. Role of homologous ASP334 and GLU319 in human non-gastric H,K- and Na,K-ATPases in cardiac glycoside binding.
Radkov R; Kharoubi-Hess S; Schaer D; Modyanov NN; Geering K; Horisberger JD
Biochem Biophys Res Commun; 2007 Apr; 356(1):142-6. PubMed ID: 17349614
[TBL] [Abstract][Full Text] [Related]
13. Cation and cardiac glycoside binding sites of the Na,K-ATPase.
Lingrel JB; Argüello JM; Van Huysse J; Kuntzweiler TA
Ann N Y Acad Sci; 1997 Nov; 834():194-206. PubMed ID: 9405808
[TBL] [Abstract][Full Text] [Related]
14. Revisiting the binding kinetics and inhibitory potency of cardiac glycosides on Na
Noël F; Azalim P; do Monte FM; Quintas LEM; Katz A; Karlish SJD
J Pharmacol Toxicol Methods; 2018; 94(Pt 2):64-72. PubMed ID: 30244071
[TBL] [Abstract][Full Text] [Related]
15. Kinetic analysis of ouabain binding to native and mutated forms of Na,K-ATPase and identification of a new region involved in cardiac glycoside interactions.
Schultheis PJ; Wallick ET; Lingrel JB
J Biol Chem; 1993 Oct; 268(30):22686-94. PubMed ID: 8226778
[TBL] [Abstract][Full Text] [Related]
16. Myocardial Na+,K(+)-ATPase in tachycardia induced cardiomyopathy.
Spinale FG; Clayton C; Tanaka R; Fulbright BM; Mukherjee R; Schulte BA; Crawford FA; Zile MR
J Mol Cell Cardiol; 1992 Mar; 24(3):277-94. PubMed ID: 1320703
[TBL] [Abstract][Full Text] [Related]
17. Uncoupling of ATP binding to Na+,K+-ATPase from its stimulation of ouabain binding: studies of the inhibition of Na+,K+-ATPase by a monoclonal antibody.
Ball WJ
Biochemistry; 1986 Nov; 25(22):7155-62. PubMed ID: 3026448
[TBL] [Abstract][Full Text] [Related]
18. Affinity labeling of a sulfhydryl group in the cardiacglycoside receptor site of Na+/K(+)-ATPase by N-hydroxysuccinimidyl derivatives of digoxigenin.
Antolovic R; Linder D; Hahnen J; Schoner W
Eur J Biochem; 1995 Jan; 227(1-2):61-7. PubMed ID: 7851443
[TBL] [Abstract][Full Text] [Related]
19. Consequences of mutations to the phosphorylation site of the alpha-subunit of Na, K-ATPase for ATP binding and E1-E2 conformational equilibrium.
Pedersen PA; Rasmussen JH; Jørgensen PL
Biochemistry; 1996 Dec; 35(50):16085-93. PubMed ID: 8973179
[TBL] [Abstract][Full Text] [Related]
20. The highly conserved cardiac glycoside binding site of Na,K-ATPase plays a role in blood pressure regulation.
Dostanic-Larson I; Van Huysse JW; Lorenz JN; Lingrel JB
Proc Natl Acad Sci U S A; 2005 Nov; 102(44):15845-50. PubMed ID: 16243970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
